RESEARCH研究

2022 研究業績・論文発表

論文

Ishii T, Mimura I, Nagaoka K, Naito A, Sugasawa T, Kuroda R, Yamada D, Kanki Y, Kume H, Ushiku T, Kakimi K, Tanaka T, Nangaku M.

Effect of M2-like macrophages of the injured-kidney cortex on kidney cancer progression.

Cell Death Discov. 2022 Dec 5;8(1):480.

Sasagawa S, Kato H, Nagaoka K, Sun C, Imano M, Sato T, Johnson TA, Fujita M, Maejima K, Okawa Y, Kakimi K, Yasuda T, Nakagawa H.

Immuno-genomic profiling of biopsy specimens predicts neoadjuvant chemotherapy response in esophageal squamous cell carcinoma

Cell Rep Med 2022 Aug 16;3(8):100705

Teshima T, Kobayashi Y, Kawai T, Kushihara Y, Nagaoka K, Miyakawa J, Akiyama Y, Yamada Y, Sato Y, Yamada D, Tanaka N, Tsunoda T, Kume H, Kakimi K

Principal component analysis of early immune cell dynamics during pembrolizumab treatment of advanced urothelial carcinoma.

Oncol Lett. 2022 Jun 16;24(2):265.

Saito N, Sato Y, Abe H, Wada I, Kobayashi Y, Nagaoka K, Kushihara Y, Ushiku T, Seto Y, Kakimi K

Selection of RNA-based evaluation methods for tumor microenvironment by comparing with histochemical and flow cytometric analyses in gastric cancer.

Sci Rep. 2022 May 20;12(1):8576.

Miyamoto A, Honjo T, Masui M, Kinoshita R, Kumon H, Kakimi K, Futami J.Engineering Cancer/Testis Antigens With Reversible S-Cationization to Evaluate Antigen Spreading

Engineering Cancer/Testis Antigens With Reversible S-Cationization to Evaluate Antigen Spreading.

Front Oncol. 2022 May 4;12:869393.

Sato S, Matsushita H, Shintani D, Kobayashi Y, Fujieda N, Yabuno A, Nishikawa T, Fujiwara K, Kakimi K, Hasegawa K.

Association between effector-type regulatory T cells and immune checkpoint expression on CD8+ T cells in malignant ascites from epithelial ovarian cancer.

BMC Cancer 2022 Apr 21;22(1):437.

Masuda T, Tanaka N, Takamatsu K, Hakozaki K, Takahashi R, Anno T, Kufukihara R, Shojo K, Mikami S, Shinojima T, Kakimi K, Tsunoda T, Aimono E, Nishihara H, Mizuno R, Oya M

Unique characteristics of tertiary lymphoid structures in kidney clear cell carcinoma: prognostic outcome and comparison with bladder cancer.

J Immunother Cancer. 2022 Mar;10(3):e003883

Komura D, Kawabe A, Fukuta K, Sano K, Umezaki T, Koda H, Suzuki R, Tominaga K, Ochi M, Konishi H, Masakado F, Saito N, Sato Y, Onoyama T, Nishida S, Furuya G, Katoh H, Yamashita H, Kakimi K, Seto Y, Ushiku T, Fukayama M, Ishikawa S.

Universal encoding of pan-cancer histology by deep texture representations.

Cell Rep 2022 Mar 1;38(9):110424.

Kawanabe-Matsuda H, Takeda K, Nakamura M, Makino S, Karasaki T, Kakimi K, Nishimukai M, Ohno T, Omi J, Kano K, Uwamizu A, Yagita H, Gomperts Boneca I, Eberl G, Aoki J, Smyth MJ, Okumura K.

Dietary Lactobacillus-derived exopolysaccharide enhances immune checkpoint blockade therapy.

Cancer Discov. 2022 Feb 17:candisc.0929.2021.

Sugawara T, Miya F, Ishikawa T, Lysenko A, Nishino J, Kamatani T, Takemoto A,Boroevich KA, Kakimi K, Kinugasa Y, Tanabe M, Tsunoda T.

Immune subtypes and neoantigen-related immune evasion in advanced colorectal cancer.

iScience. 2022 Jan 6;25(2):103740.